Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Neuropathology and Experimental Neurology

• Publication date

  2011-11-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/NEN.0b013e318232a379PMID 22002422
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alzheimer’s pathogenesis: is there neuron-to-neuron propagation?

  2011cited by this paper
• Alzheimer’s disease is not “brain aging”: neuropathological, genetic, and epidemiological human studies

  2011cited by this paper
• Seeding of Normal Tau by Pathological Tau Conformers Drives Pathogenesis of Alzheimer-like Tangles*

  2011cited by this paper
• Propofol Directly Increases Tau Phosphorylation

  2011cited by this paper
• The pathological process underlying Alzheimer’s disease in individuals under thirty

  2011influential reference
• Why Pleiotropic Interventions are Needed for Alzheimer's Disease

  2010cited by this paper
• Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders

  2010cited by this paper
• Neural mechanisms of ageing and cognitive decline

  2010cited by this paper
• The Effect of Prolonged Fixation Time on Immunohistochemical Staining of Common Neurodegenerative Disease Markers

  2010cited by this paper
• Neuropathology of non-Alzheimer degenerative disorders.

  2010cited by this paper
• Transition of Tau Protein from Disordered to Misordered in Alzheimer’s Disease

  2010cited by this paper
• Reimagining Alzheimer's Disease—An Age-Based Hypothesis

  2010cited by this paper
• The propagation of prion-like protein inclusions in neurodegenerative diseases.

  2010cited by this paper
• Reactive Oxygen Species: Stuck in the Middle of Neurodegeneration

  2010cited by this paper
• Protein Targets of Oxidative Damage in Human Neurodegenerative Diseases with Abnormal Protein Aggregates

  2010cited by this paper
• Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo

  2010cited by this paper
• Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

  2010cited by this paper
• The locus coeruleus and noradrenergic modulation of cognition

  2009cited by this paper
• Reassessing the amyloid cascade hypothesis of Alzheimer's disease.

  2009cited by this paper
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• Mechanisms of tau-induced neurodegeneration

  2009cited by this paper
• The dorsal raphe nucleus shows phospho‐tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?

  2009cited by this paper
• Does Alzheimer's disease begin in the brainstem?

  2009cited by this paper
• Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship

  2009cited by this paper
• Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium

  2008cited by this paper
• Cholinergic Neuronal and Axonal Abnormalities Are Present Early in Aging and in Alzheimer Disease

  2008cited by this paper
• Prodromal Alzheimer's disease: Successive emergence of the clinical symptoms

  2008cited by this paper
• Functional consequences of locus coeruleus degeneration in Alzheimer's disease.

  2008cited by this paper
• Argyrophilic grain disease.

  2008cited by this paper
• Argyrophilic grain disease.

  2008cited by this paper
• The amyloid cascade hypothesis

  2008cited by this paper
• Seeding Neuritic Plaques from the Distance: A Possible Role for Brainstem Neurons in the Development of Alzheimer’s Disease Pathology

  2008cited by this paper
• Mechanism of tau-induced neurodegeneration in Alzheimer disease and related tauopathies.

  2008cited by this paper
• The aging brain.

  2008cited by this paper
• Neurofibrillary changes of the Alzheimer type in very elderly individuals: neither inevitable nor benign: Commentary on "No disease in the brain of a 115-year-old woman".

  2007cited by this paper
• Structural Principles of Tau and the Paired Helical Filaments of Alzheimer’s Disease

  2007cited by this paper
• Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau

  2007cited by this paper
• Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease.

  2007cited by this paper
• A Century of Alzheimer's Disease

  2006cited by this paper
• The Amyloid Hypothesis: history and alternatives

  2006cited by this paper
• Molecular and cellular pathways towards and away from Alzheimer’s disease

  2006cited by this paper
• Locus ceruleus degeneration is ubiquitous in Alzheimer’s disease: Possible implications for diagnosis and treatment

  2006cited by this paper
• Tau protein, the paired helical filament and Alzheimer's disease

  2006cited by this paper
• Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

  2006cited by this paper
• An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance.

  2005cited by this paper
• Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology.

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Alzheimer’s disease: intraneuronal alterations precede insoluble amyloid-β formation

  2004cited by this paper
• A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads

  2004cited by this paper
• Alzheimer's disease: intraneuronal alterations precede insoluble amyloid-beta formation.

  2004cited by this paper
• Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases.

  2003cited by this paper
• Staging of brain pathology related to sporadic Parkinson's disease.

  2003cited by this paper
• Phases of Aβ-deposition in the human brain and its relevance for the development of AD

  2002cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress

  2002cited by this paper
• Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils

  2001cited by this paper
• Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP

  2001cited by this paper
• The selective vulnerability of brainstem nuclei to Alzheimer's disease

  2001cited by this paper
• Evolution of Alzheimer’s disease-related cytoskeletal changes in the basal nucleus of Meynert

  2000cited by this paper
• “Fatal Attractions” of Proteins: A Comprehensive Hypothetical Mechanism Underlying Alzheimer's Disease and Other Neurodegenerative Disorders

  2000cited by this paper
• Sequence of Aβ‐Protein Deposition in the Human Medial Temporal Lobe

  2000cited by this paper
• Sequence of Abeta-protein deposition in the human medial temporal lobe.

  2000cited by this paper
• Neurons may live for decades with neurofibrillary tangles.

  1999cited by this paper
• Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: a regional quantitative analysis.

  1998cited by this paper
• Duration of neurofibrillary changes in the hippocampal pyramidal neurons.

  1998cited by this paper
• Frequency of stages of Alzheimer-related lesions in different age categories.

  1997cited by this paper
• Spatial, temporal and numeric analysis of Alzheimer changes in the nucleus coeruleus.

  1997cited by this paper
• Frequency of stages of Alzheimer-related lesions in different age categories.

  1997cited by this paper
• Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.

  1996cited by this paper
• Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes.

  1995cited by this paper
• Alzheimer's disease is a laminar, regional, and neural system specific disease, not a global brain disease.

  1994cited by this paper
• The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development.

  1993cited by this paper
• Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections

  1991cited by this paper
• Is Alzheimer's disease an anterograde degeneration, originating in the brainstem, and disrupting metabolic and functional interactions between neurons and glial cells?

  1989cited by this paper
• The neuropathology of aminergic nuclei in Alzheimer's disease.

  1988cited by this paper
• The neuropathology of aminergic nuclei in Alzheimer's disease

  1988cited by this paper
• Argyrophilic grains: characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes.

  1987cited by this paper
• Alzheimer's disease: Neurofibrillary tangles in nuclei that project to the cerebral cortex

  1987cited by this paper
• Human brainstem catecholamine neuronal anatomy as indicated by immunocytochemistry with antibodies to tyrosine hydroxylase.

  1983cited by this paper

• High-resolution [18F]MK-6240 PET in Alzheimer's disease.

  2026cites this paper
• Sex-dependent locus coeruleus vulnerability in Alzheimer’s disease: gut dysbiosis as a driver and probiotic intervention as rescue

  2026cites this paper
• Inflammatory mechanisms underlying early Alzheimer's disease pathology: evidence from the aging rhesus macaque brain.

  2026cites this paper
• Synthesis and Evaluation of Radioiodinated [125I]7‐Iodo‐5H‐Pyrido[4,3‐B]Indole ([125I]CTAU) in Postmortem Human Alzheimer's Disease Brain

  2026cites this paper
• Female‐biased astrocytic priming shapes early locus coeruleus vulnerability in an Aβ oligomer milieu

  2026cites this paper
• Impaired LC-NE System—A Novel Molecular Mechanism Underlying Health Disparity and Increased Prevalence of Alzheimer’s Disease Among African Americans

  2026cites this paper
• Experiences of Personalized Dementia Risk Education: A Qualitative Study to Refine the TEACH (Tailored Education for Aging and Cognitive Health) Behavioral Intervention

  2026cites this paper
• Noradrenergic innervation across brain regions is altered by aging and by disease progression in a mouse model of Alzheimer's disease neuropathology.

  2026cites this paper
• Acupuncture-induced changes in locus coeruleus connectivity and memory improvement in patients with amnestic cognitive impairment

  2026cites this paper
• Characterizing amyloid and tau positron emission tomography‐based stages across the clinical continuum

  2026cites this paper
• Incidence of altered proteins in the aging brain: Implications for biological diagnostic markers

  2026cites this paper
• Deep learning models identify brain changes during the progression of Alzheimer's disease.

  2026cites this paper
• Graph Neural Network Reveals the Local Cortical Morphology of Brain Aging in Normal Cognition and Alzheimer’s Disease

  2026cites this paper
• Exogenous Aβ1-42 Monomers Rescue Memory Deficits in Presenilin-1 and Presenilin-2 Conditional Double Knockout Mice.

  2026cites this paper
• Sex-specific patterns in tau spreading throughout the Braak stages in the Alzheimer’s disease spectrum

  2026cites this paper
• Global brain activity links subcortical degeneration to cortical tau progressively across Braak regions over early Alzheimer’s disease stages

  2026cites this paper
• Greater locus coeruleus vulnerability in atypical clinicopathologic forms of Alzheimer's disease

  2026cites this paper
• Sleep disturbances and Alzheimer's disease: a multiscale approach from exposome to neurobiology and precision medicine.

  2026cites this paper
• Resting-State Cerebral Blood Flow and Its Disconnect From Functional Connectivity in Alzheimer's Disease Spectrum.

  2026cites this paper
• Hyperphosphorylated tau and amyloid-β proteinopathy in people over age 50: Findings from the Lieber Institute for Brain Development Brain Donation Repository

  2026cites this paper
• Comparing Gallyas and AT8 staining for quantification of tau pathology in subregions of the human hippocampus.

  2026cites this paper
• End-to-end susceptibility-induced distortion correction for diffusion MRI with unsupervised deep learning

  2026cites this paper
• The monoaminergic systems as drivers of Alzheimer's disease pathophysiology and symptomatology.

  2026cites this paper
• Impaired adrenergic regulation of Kv channels underlies LC hyperactivity and early‐onset sleep disruption in AD‐like amyloidogenic mice

  2026cites this paper
• Impact of Cognitive Load on Pupil Dilation: A Comparative Study of Young and Older Adults.

  2026cites this paper
• Exploring the pathogenic mechanisms of dementia risk factors: a task-fMRI study of mild cognitive impairment

  2026cites this paper
• Pathogenic tau in the mouse locus coeruleus produces noradrenergic hyperactivity and neuropsychiatric phenotypes reminiscent of early Alzheimer’s disease

  2026cites this paper
• Blood oxygenation level-dependent responses in neuromodulatory nuclei and their associations with attention and memory across age groups.

  2025cites this paper
• Deconfounded and debiased estimation for high-dimensional linear regression under hidden confounding with application to omics data

  2025cites this paper
• Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN‐TU‐001 trial

  2025cites this paper
• Locus coeruleus integrity correlates with plasma soluble Axl levels in Alzheimer's disease patients

  2025cites this paper
• Comparing handheld monoscopic and head-mounted stereoscopic optical see-through augmented reality indoor navigational aids across age and gender identity

  2025cites this paper
• Uric Acid, the End-Product of Purine Metabolism, Mitigates Tau-Related Abnormalities: Comparison with DOT, a Non-Antibiotic Oxytetracycline Derivative

  2025cites this paper
• Dysregulated calcium signaling in the aged primate association cortices: vulnerability to Alzheimer’s disease neuropathology

  2025cites this paper
• Disease‐specific neuropathological alterations of the locus coeruleus in Alzheimer's disease, Down syndrome, and Parkinson's disease

  2025cites this paper
• Telomere-driven senescence accelerates tau pathology, neuroinflammation and neurodegeneration in a tauopathy mouse model

  2025cites this paper
• The increase in TDP-43 and neurogranin blood levels at different stages of cognitive impairment in the elderly people: A cross-sectional study

  2025cites this paper
• Noradrenaline Regulation of Brain-Body Communication.

  2025cites this paper
• Sequence and trajectory of early Alzheimer’s disease-related tau inclusions in the hippocampal formation of cases without amyloid-β deposits

  2025influential citation
• Dysregulated Neurotransmitters and CB1 Receptor Dysfunction and Their Roles in Agitation Associated with Alzheimer’s Disease

  2025cites this paper
• Long-term Nrf2-driven microglial repopulation mitigates microgliosis, neuronal loss and cognitive deficits in tauopathy

  2025cites this paper
• Multimodal neuroimaging unveils basal forebrain-limbic system circuit dysregulation in cognitive impairment with depression: a pathway to early diagnosis and intervention

  2025influential citation
• Early emergence of motivational and hedonic feeding deficits in the TgF344-AD rat model of Alzheimer’s disease

  2025cites this paper
• Lower locus coeruleus integrity is associated with diminished practice effects in clinically unimpaired older individuals.

  2025cites this paper
• 2025 Alzheimer's disease facts and figures

  2025cites this paper
• Medial temporal lobe atrophy in Down syndrome along the Alzheimer's disease continuum.

  2025cites this paper
• Correlation analyses between MIBG myocardial scintigraphy and monoamine levels in dementia with Lewy bodies show potential link with the serotonergic system

  2025cites this paper
• Alzheimer's Disease and Frontotemporal Dementia: A Review of Pathophysiology and Therapeutic Approaches

  2025cites this paper
• Mapping the hippocampal spatial proteomic signature in male and female mice of an early Alzheimer’s disease model

  2025cites this paper
• Multisite chronic pain: association with cognitive decline and post-mortem Alzheimer’s biomarkers

  2025cites this paper
• Non-coding variation in dementias: mechanisms, insights, and challenges

  2025cites this paper
• Neurotoxic Effects of Airborne Particulate Matter: Mechanisms and Health Implications

  2025cites this paper
• Brain-derived extracellular vesicle microRNAs in Lewy body and Alzheimer’s disease

  2025cites this paper
• Brain Region-specific Accumulation of Amyloidosis-associated Proteins in Postmortem Brain Tissues of Alzheimer’s Disease Patients

  2025cites this paper
• Unveiling of the novel benzothiazole derived thiazolidinone derivatives: in vitro and in silico insights to design a promising agent for anti-Alzheimer’s disease

  2025cites this paper
• Shifting focus to preclinical stages: Locus coeruleus tau pathology as a driver and therapeutic target in Alzheimer's disease.

  2025cites this paper
• Joint spatial associations of amyloid beta and tau pathology in Down syndrome and preclinical Alzheimer's disease: Cross‐sectional associations with early cognitive impairments

  2025cites this paper
• Impact of Lysine Acetylation Mutations on the Structure of Full-Length Tau Fibrils.

  2025cites this paper
• Variation in follow-up care after a new diagnosis of memory loss or cognitive impairment in a major health system

  2025cites this paper
• The Effects of Mindfulness Meditation on Mechanisms of Attentional Control in Young and Older Adults: A Preregistered Eye Tracking Study

  2025cites this paper
• Autophagy and Cellular Senescence in Alzheimer's Disease: Key Drivers of Neurodegeneration

  2025cites this paper
• Brain Region-Specific Accumulation of Amyloidosis-Associated Proteins in Postmortem Brain Tissues of Alzheimer’s Disease Patients

  2025cites this paper
• GluN2B of NMDA receptor and Calmodulin: Ameliorate calcium homeostasis for the mitigation of Alzheimer disease

  2025cites this paper
• RNA‐Based Therapies for Neurodegenerative Diseases Targeting Pathogenic Proteins

  2025influential citation
• Sulforaphane prevents cognitive decline and mitochondrial failure induced by hippocampal expression of caspase-3 cleaved tau.

  2025cites this paper
• Beneficial effects of mitophagy enhancers on amyloid beta-induced mitochondrial and synaptic toxicities in Alzheimer's disease.

  2025cites this paper
• Targeting of phosphorylated tau at threonine 181 by a Qβ virus‐like particle vaccine is safe, highly immunogenic, and reduces disease severity in mice and rhesus macaques

  2025cites this paper
• Alzheimer mimicry: LATE and PART

  2025cites this paper
• Pathways underlying selective neuronal vulnerability in Alzheimer's disease: Contrasting the vulnerable locus coeruleus to the resilient substantia nigra

  2025cites this paper
• Transcriptional signatures of hippocampal tau pathology in primary age-related tauopathy and Alzheimer’s disease

  2025cites this paper
• Reduction in [18F]Nifene Binding, a PET imaging Probe for α4β2* Nicotinic acetylcholinergic receptors in Hippocampus-Subiculum of postmortem human Alzheimer’s disease brain

  2025cites this paper
• Blood-Based Protein Biomarkers in the Chronic Phase of Traumatic Brain Injury: A Systematic Review

  2025cites this paper
• The cholinotrophic system in Down syndrome.

  2025cites this paper
• Locus coeruleus tau validates and informs high-resolution MRI in aging and at earliest Alzheimer’s pathology stages

  2025influential citation
• Probing locus coeruleus functional network in healthy aging and its association with Alzheimer’s disease biomarkers using pupillometry

  2025cites this paper
• Diffusion tensor subspace imaging of double diffusion–encoded MRI delineates small fibers and gray‐matter microstructure not visible with single encoding techniques

  2025cites this paper
• Locus Coeruleus Sexual Dimorphism and Its Impact on Cognitive Impairment and Cortical Atrophy in Alzheimer’s Disease

  2025cites this paper
• Fading Blue: Exploring the Causes of Locus Coeruleus Damage Across the Lifespan

  2025cites this paper
• Early signs of neuron autonomous and non‐autonomous hyperexcitability in locus coeruleus noradrenergic neurons of a mouse model of tauopathy and Alzheimer's disease

  2025cites this paper
• Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers

  2025influential citation
• The neuropathologic basis for translational biomarker development in the macaque model of late-onset Alzheimer's disease

  2025influential citation
• Decreased practice effects in cognitively unimpaired amyloid betapositive individuals: a multicenter, longitudinal, cohort study

  2025cites this paper
• Brain morphology mediating the effects of common genetic risk variants on Alzheimer’s disease

  2025cites this paper
• Autonomic dysfunction in neurodegenerative disease

  2025cites this paper
• Monoaminergic Alterations at the Subregional Cervical and Thoracic Spinal Cord Level of Patients Within the FTD‐ALS Continuum and Early‐Onset AD: Low Thoracic Dopaminergic Activity in ALS

  2025cites this paper
• Optimized 5‐HT2b inhibitors for neuropsychiatric syndromes with cognitive dysfunction

  2025cites this paper
• Loneliness and biomarkers of brain pathology in people with subjective cognitive decline

  2025cites this paper
• Mechanism of Tau Protein Incorporation into Exosomes via Cooperative Recognition of KFERQ-like Motifs by LAMP2A and HSP70.

  2025cites this paper
• Human MAPT knockin mouse models of frontotemporal dementia for the neurodegenerative research community

  2025cites this paper
• A mouse model of early sporadic tau pathology induces neurogenic plasticity in the hippocampus

  2025cites this paper
• [18F]Mefway: Imaging Serotonin 5HT1A Receptors in Human Postmortem Alzheimer’s and Parkinson’s Disease Anterior Cingulate. Potential Applications to Human Positron Emission Tomography Studies

  2025cites this paper
• Monoaminergic signaling during mammalian NREM sleep - Recent insights and next-level questions.

  2025cites this paper
• Microstructural assessment of the locus coeruleus–entorhinal cortex pathway and association with ATN markers in cognitive impairment

  2025cites this paper
• Alzheimer's disease and the immune system: A comprehensive overview with a focus on B cells, humoral immunity, and immunotherapy

  2025cites this paper
• Partial normalization of hippocampal oscillatory activity during sleep in TgF344-AD rats coincides with increased cholinergic synapses at early-plaque stage of Alzheimer’s disease

  2025cites this paper
• Locus coeruleus-related insula activation supports implicit learning

  2025cites this paper
• pS396/pS404 (PHF1) tau vaccine outperforms pS199/pS202 (AT8) in rTg4510 tauopathy model

  2025cites this paper
• Mechanical stimulation prevents impairment of axon growth and overcompensates microtubule destabilization in cellular models of Alzheimer’s disease and related Tau pathologies

  2025cites this paper
• Alcohol consumption during early adulthood increases the vulnerability of locus coeruleus neurons and amyloid beta pathology in female APP/PS1 mice.

  2025cites this paper
• Neurostimulation devices to treat Alzheimer’s disease

  2025cites this paper